Search results
Left in limbo: When pharma halts rare disease research
Pharmaceutical Technology· 17 hours agoThe overall survival with the gene therapy was 100% in all studies up to 36 months. Event-free ...
The overall survival with the gene therapy was 100% in all studies up to 36 months. Event-free ...